1-2 of 2
Miriam E. Mossoba, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pre-Emptive T-Rapa Cell DLI for Therapy of High-Risk Lymphoma After Low-Intensity Allogeneic HCT

David Halverson, MD, Miriam E. Mossoba, PhD, Seth M. Steinberg, PhD, Bazetta blacklock-Schuver, Frances T. Hakim, PhD, Roger Kurlander, MD, Juan Gea-Banacloche, MD, Claude Sportes, MD, Nancy M. Hardy, MD, Dennis D. Hickstein, M.D., Steven Z. Pavletic, MD, Hanh Khuu, MD, Marianna Sabatino, MD, David Stroncek, MD, Susan F. Leitman, MD, Scott D. Rowley, MD, Michele L. Donato, MD, Andre Goy, MD, Robert Korngold, PhD, Andrew L. Pecora, MD, Bruce L. Levine, PhD, Carl H. June, MD, Michael R. Bishop, MD, Carol Carini, Tatyana Feldman, MD, Anthony R. Mato, MD, Ronald E. Gress, MD, Daniel H. Fowler, MD
Journal: Blood
Blood (2012) 120 (21): 471.
https://doi.org/10.1182/blood.V120.21.471.471
Published: 2012
Journal Articles

T-Rapa Cell Clinical Products Contain a Balance of Minimally Differentiated Th2/Th1 Effector Cells Depleted of Treg Cells

Miriam E. Mossoba, PhD, Jacopo Mariotti, MD, Xiao-Yi Yan, Anu Gangopadhyay, Mathew Winterton, Marianna Sabatino, MD, Hanh Khuu, MD, Vicki Fellowes, Frances T. Hakim, PhD, David Stroncek, MD, Susan Leitman, MD, Bruce L Levine, PhD, Carl H. June, MD, Daniel H Fowler, MD
Journal: Blood
Blood (2010) 116 (21): 352.
https://doi.org/10.1182/blood.V116.21.352.352
Published: 2010